RT Journal Article
SR Electronic
A1 Lederman, Lynne
T1 Benefit of Extended Anticoagulation After Unprovoked PE Lost After Treatment Discontinuation
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 55
SP 11
OP 11
DO 10.1177/1559897714568629
UL http://mdc.sagepub.com/content/14/55/11.abstract
AB After a first episode of unprovoked pulmonary embolism initially treated during 6 months, extending anticoagulant therapy with warfarin for an additional 18 months significantly reduces the risk of recurrent venous thromboembolism. However, by 2 years after therapy is discontinued, the risk of recurrent thrombolic events is no different between the warfarin treatment group and the placebo group.